The protein tyrosine phosphatase1B (PTP1B) is a negative regulator of both insulin and leptin signaling, and shows a highly validated therapeutic target for the treatment of diabetes and obesity (Zhang and Zhang, 2007). Here, LEP is linked to diabetes mellitus.